期刊文献+

人B7-H4-Fc融合蛋白的表达及其应用研究 被引量:2

Study on the Preparation of B7-H4-Fc Fusion Protein and Its Application
下载PDF
导出
摘要 B7-H4分子是近年发现的一个新的协同刺激分子,它通过抑制T细胞的增殖、细胞因子的分泌以及细胞周期的进行,进而下调T细胞的免疫功能。为获取人B7.H4IgG融合蛋白,研究其对T细胞的调节效应,采用PCR法分别从pEGZ—Term/PD—L1-Fc和含人B7.H4基因序列的重组质粒中扩增出人IgGFc恒定区基因及人B7+H4基因的胞外段序列,将两者插入逆转录病毒载体pEGZ—Term中,构建pEGZ.Term/B7.H4一Fc逆转录病毒重组载体,用脂质体法与两个辅助病毒载体共转染293T包装细胞,用含病毒颗粒的培养上清反复感染CHO细胞。用Zeocin筛选能稳定分泌人B7-H4-Fc融合蛋白的基因转染细胞并亚克隆之,经大量培养增殖,裂解细胞后收集裂解上清用ProteinG柱纯化,再经Westernblot鉴定。以体外T细胞活化体系观察其对T细胞活化的抑制作用。结果表明,成功地构建了表达人B7-H4-Fc融合蛋门的重组逆转录病毒载体;获得的CHO/B7-H4-Fc细胞能稳定分泌人B7-H4-Fc融合蛋门,该融合蛋白可以有效地抑制T细胞的活化。 B7-H4 is a recently discovered co-stimulatory molecules,which can regulate down the T cells immune function by inhibiting T cell proliferation,secreting cytokine and interrupting cell cycle.In order to stably express human B7-H4-Fc fusion protein in eukaryon cells and to investigate the regulatory effect on T cells,extracellular domain of human B7-H4 gene was amplified by PCR from a recombinant plasmid containing human B7-H4 gene,and human IgG I (Fc) constant region was obtained through PCR from pEGZ-Term/PD-L1- Fc.The two amplified genes were inserted into the reverse transcriptase virus vector pEGZ-Term,and constructed the pEGZ-Term/B7-H4-Fc vector.The recombinant vector together with its 2 helper virus vector was cotransfected into the package cell 293T.The supernatant of 293T containing intact virus granules was used to infect CHO cells. The gene infected cells stably secreting human B7-H4-Fc fusion protein were selected by Zeocin,then subcloned and cultured.B7-H4-Fc fusion protein was purified by Protein G column from the gene infected cells lysis supernatant,and identified by Western blot.B7-H4-Fc fusion protein precoated on the 96 wells of plates was used to detect its influence on the T cells activated by agonistic anti-CD3 mAb and anti-CD28 mAbs.The results showed that recombinant retro virus vector carrying human B7-H4-Fc fusion gene was constructed successfully and CHO/ B7-H4-Fc cells stably secreting human B7-H4-Fc fusion protein were obtained and confirmed.The activation of T cells was obviously inhibited by B7-H4-Fc fusion protein in vitro.B7-H4-Fc fusion protein will contribute to further research on the function of B7-H4 molecule.
出处 《中国血液流变学杂志》 CAS 2013年第2期221-225,共5页 Chinese Journal of Hemorheology
关键词 B7-H4-Fc融合蛋白 T细胞活化 抑制 B7-H4-Fc fusion protein T cells activation inhibition
  • 相关文献

参考文献7

  • 1Bretscher P, Cohn M.A theory of self-nonself discrim- ination[J].Science,1970,169(3950):1042- 1049.
  • 2Lanzavecchia A,Lezzi G,Viola A.From TCR engagement to T cell activation:a kinetic view of T cell behavior[J]. Cell,1999,96(1):1 - 4.
  • 3Chambers CA.The expanding world of co-stimulation:the two-signal model revisited[J].Trends Immunol,2001, 22(4):217 - 223.
  • 4Sica GL,Choi IH,Zhu G,et al.B7-H4,a molecule of the B7 family,negatively regulates T cell immunity[J].Immunity, 2003,18(6):849 - 861.
  • 5He Y, Lu H,Siddiqui P, et al.Receptor-binding domain of severe acute respiratory syndrome eoronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies[J].J Immunol,2005,174(8):4908 - 4915.
  • 6陈永井,姜智,张光波,毛一香,瞿秋霞,葛彦,杨明峰,张学光.人PD-L1Ig融合蛋白的表达及其生物学活性的研究[J].现代免疫学,2004,24(6):449-454. 被引量:5
  • 7Zang X,Loke P, Kim J,et al.B7x:a widely expressed B7 family member that inhibits T cell activation[J].Proc Natl Acad Sci U S A,2003,100(18):10388 - 10392.

二级参考文献17

  • 1Bretscher PA,Coln M. A theory of self and non self discrimination[J]. Science,1970,169:1042.
  • 2Lanzavecchia A,Lezzi G,Viola A. From TCR engagement to T cell activation:a kinetic view of T cell behavior[J]. Cell,1999,96:1.
  • 3Chambers CA. The expanding world of co-stimulation:the two-signal model revisited[J]. Trends Immunol,2001,22:217.
  • 4Nimura H,Honjo T. PD-1:an inhibitory immunoreceptor involved in peripheral tolerance[J]. Trends Immunol,2001,22:265.
  • 5Watanabe N,Gavrieli M,Sedy JR,et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1[J]. Nat Immunol,2003,4:670.
  • 6Dong HD,Zhu GF,Tamada K,et al. B7-H1,a third member of the B7 family,co-stimulates T-cell proliferation and interleukin-10 secretion[J]. Nat Med,1999,5:1365.
  • 7Latchman Y, Wood CR, Chernnova T,et al. PD-L2 is a second ligand for PD-1 and inhibit T cell activation[J]. Nat Immunol,2001,2:261.
  • 8Freeman GJ,Long AJ,Iwai Y,et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphcyte activation[J]. J Exp Med,2000,192:1027.
  • 9Carter LL,Fouser LA, Jussif J, et al. PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+T cells and is overcomed by IL-2[J]. Eur J Immunol,2002,32:634.
  • 10Dong HD,Strome SE,Salomao DR,et al. Tumor-associated B7-H1 promotes T-cell apoptosis:a potential mechanism of immune evasion[J]. Nat Med,2002,8:793.

共引文献4

同被引文献19

  • 1Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses[J]. Annu Rev Immunol, 2002, 20: 29 - 53.
  • 2Jung K, Choi I. Emerging Co-signaling Networks in T Cell Immune Regulation[J]. Immune Netw, 2013, 13(5): 184- 193.
  • 3Sica GL, Choi IH, Zhu G, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity[J]. Immunity, 2003, 18(6): 849 - 861.
  • 4Flies DB, Chen L. The new B7s: playing a pivotal role in tumor immunity[J]. J Immunother, 2007, 30(3): 251 - 260.
  • 5Tringler B, Liu W, Corral L, et al. B7-H4 overexpression in ovarian tumors[J]. Gynecol Oncol, 2006, 100(1): 44 - 52.
  • 6Salceda S, Tang T, Kmet M, et al. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation[J]. Exp Cell Res, 2005, 306(1): 128 - 141.
  • 7Krambeck AE, Thompson RH, Dong H, et al. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival[J]. Proc Natl Acad Sci U S A, 2006, 103(27): 10391 - 10396.
  • 8He C, Qiao H, Jiang H, et al. The inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survival[J]. Clin Dev Immunol, 2011,2011 : 695834.
  • 9Zhang N, Fang P, Gu ZJ. Preparation and characterization of monoclonal antibody against human B7-H4 molecule[J]. Monoclon Antib Immunodiagn Immunother, 2014, 33(4): 270 - 274.
  • 10Dangaj D, Lanitis E, Zhao A, et al. Novel recombinant human b7-h4 antibodies overcome mrnoral immtme escape to potentiate T-cell antitumor responses[J]. Cancer Res, 2013, 73(15): 4820 - 4829.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部